What is Micro-Leads?
Micro-Leads is at the forefront of precision neuromodulation therapy, leveraging a sophisticated closed-loop platform for high-resolution, minimally-invasive nerve stimulation. The company has developed advanced therapeutic solutions encompassing spinal cord stimulation, peripheral nerve stimulation, and brain-computer interfaces. Their expertise is evident in their programmable electrodes and neurostimulators, designed to deliver personalized therapies through closed-loop sensing technology. Micro-Leads primarily serves clients within the medical sector, focusing on neuromodulation and the development of therapeutic devices.
How much funding has Micro-Leads raised?
Micro-Leads has raised a total of $10M across 1 funding round:
Other Financing Round
$10M
Other Financing Round (2019): $10M with participation from National Institutes of Health
Key Investors in Micro-Leads
National Institutes of Health
The National Institutes of Health (NIH) is a primary agency of the U.S. Department of Health and Human Services, dedicated to biomedical and health-related research. Their involvement suggests a strong validation of Micro-Leads' therapeutic technology and potential impact on public health.
What's next for Micro-Leads?
The substantial enterprise-level funding and recent strategic investment indicate a pivotal growth phase for Micro-Leads. This capital infusion is expected to accelerate the development and commercialization of their advanced neuromodulation technologies, potentially expanding their market reach in therapeutic devices and brain-computer interfaces. The company is well-positioned to further its mission of delivering personalized therapies, likely focusing on scaling production, enhancing their closed-loop platform, and forging new partnerships within the medical and research communities.
See full Micro-Leads company page
